Q heads into the second half of May with fresh momentum and a Wall Street upgrade cycle that is still in motion.
The stock added 9.9% on Tuesday alone and is up nearly 15% for the week, after reporting Q1 earnings that beat on every line. Adjusted EPS of $1.08 came in well ahead of the $0.92 estimate. Revenue of $1.315 billion beat by $44 million. The company then raised full-year adjusted EPS guidance to $3.80–$4.14 against a prior consensus of $3.71, and lifted its sales outlook to $5.225–$5.375 billion versus the $5.123 billion the Street had pencilled in. That combination — beat plus raise — drove the gap-up and set the stage for a week that has seen Q outperform virtually every name in its peer group.
The divergence from peers is sharp. While Q rallied 15% on the week, close correlates ENTG and CAMT shed 2.7% and 11.4% respectively. ONTO fell 8.9%. Only MKSI and managed anything close to Q's move, gaining 8.4% and 5.0% respectively. The relative strength here is notable — Q is trading like a company that just delivered a structurally cleaner print than its sector.
Options positioning tells the bull case in numbers. The put/call ratio dropped to 0.28 on the day of the print — two standard deviations below its 20-day average of 0.45, and near the lowest reading of the past year. Calls dominated heavily, with buyers flooding in ahead of the result. That demand for upside exposure had been building for several sessions; the ORTEX news flagged unusual call buying as early as May 13 morning. The RSI14 is now at 75.4, technically overbought territory, but the momentum here is driven by genuine fundamental re-rating rather than speculative froth. Borrow conditions are relaxed. Availability is essentially unlimited at 9,999% of short interest, cost to borrow has fallen 23% over the week to just 0.27% — the lending market is wide open. The short score of 30.2 is modest and barely budged on the week. This is not a heavily contested name.
Analysts are repricing the stock quickly. RBC Capital's Arun Viswanathan raised his target from $150 to $200 today while maintaining Outperform — a 33% lift that takes his view well above the current mean price target of $173. Mizuho followed with a move from $150 to $170, also reiterating Outperform. Both raises came within hours of each other on May 13, the day after the print. This is the third consecutive target raise from RBC since February, tracking from $118 to $133 to $139 to $150 and now $200 — a consistent upward drift that reflects a thesis building over several months, not a one-quarter reaction. The mean target still trails the stock at $173 versus a close of $168, implying the Street has more work to do to fully absorb the beat-and-raise.
Valuation has re-rated accordingly. The P/E has expanded to 39.4x, up roughly 5 points over the past 30 days. EV/EBITDA is at 23.5x, also up on the week and month. Neither multiple is unusual for a high-growth semiconductor materials name that is delivering positive guidance revisions, but at these levels the stock is priced for continued execution. The one quiet note of caution comes from insiders. A cluster of executives — including CEO Jon Kemp — sold small parcels at $141.76 on May 4, shortly before the earnings catalyst. These were modest in size and all carried a significance score of 1, the lowest tier. They look like routine plan sales rather than a directional signal. The February tranche, where Kemp sold 4,555 shares at $113.72, was larger but similarly low-significance.
With the next scheduled event on May 19, the week ahead will test whether the post-earnings momentum holds or consolidates. The key question is whether the Street's remaining price target gap — several analysts still have targets in the $150s or below — closes via fresh upgrades or by the stock pulling back toward consensus.
See the live data behind this article on ORTEX.
Open Q on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
